VR Mindfulness for People With HIV and Substance Use
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorTulane University
About this trial
The goal of this clinical trial is to explore whether a virtual reality (VR) mindfulness app is acceptable, appropriate, and feasible for supporting people with HIV and substance use problems.
Participants will:
* Use a VR headset with a mindfulness app at home; * Complete three online surveys over three months; * Take part in an individual interview or focus group to share their experiences.
Eligibility criteria
Qualifiers
Able to speak, read, and write in English
Aged 18 years or older
Diagnosed with HIV
Currently prescribed ART therapy
Disqualifiers
Living in institutionalized settings or unsheltered
Terminal illness with a life expectancy of less than 6 months
Planning to move out of the area in the next eight weeks
Engaging in regular mindfulness practice outside of TRIPP
Trial design
Treatments tested in this trial
- TRIPP
Treatment groups
30 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov